Advisory Services Network’s DiaMedica Therapeutics DMAC Stock Holding History
Bought
Maintained
Sold
Other funds holding DMAC
CLG
JAMONY
Advisory Services Network's DMAC Position: Q1 2023 in Review
Advisory Services Network sold out of DiaMedica Therapeutics (DMAC) in Q1 2023, closing a stake of 1,500 shares — an estimated $2.37K sold.
Advisory Services Network first reported a position in DMAC in Q4 2022 and held it in 1 quarter. The position peaked at $2.37K in Q4 2022. 25 funds tracked by Wall St. Rank hold DMAC as of Q1 2023.
- Advisory Services Network reported no remaining DiaMedica Therapeutics position as of Q1 2023 after selling out during the quarter.
- Advisory Services Network sold 1,500 DiaMedica Therapeutics shares in Q1 2023, an estimated $2.37K.
- Advisory Services Network first reported a position in DiaMedica Therapeutics in Q4 2022 and held it in 1 quarter.
- Advisory Services Network's DiaMedica Therapeutics position peaked at $2.37K in Q4 2022.
- 25 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q1 2023.
Based on Advisory Services Network's 13F filing for Q1 2023, filed 17 May 2023.